InvestorsHub Logo
Followers 2
Posts 245
Boards Moderated 0
Alias Born 09/09/2005

Re: None

Thursday, 09/15/2005 1:53:34 AM

Thursday, September 15, 2005 1:53:34 AM

Post# of 30387
I know its old news but look how bocx laid to us:

BioCurex, Inc. (OTCBB:BOCX) announces that the prestigious trade journal IVD Technology (In-vitro Diagnostic Technology) has invited BioCurex's President, Dr. Ricardo Moro, to write an article to be published in the journal.

The invitation to write the article in the journal was the result of a presentation by Dr. Moro on the RECAF(TM) technology in a cancer congress where many of the major drug companies attended.

The article will focus on the applications of the Histo-RECAF(TM) kit that has recently obtained FDA APPROVAL and is included in the patent granted by the U.S. Patent Office and granted or pending in over 20 other countries.

hesto-recaf was NEVER APPROVED BY THE FDA ??!! why this company was lying to us longs about the FDA aprroval ?!
the SEC suspended trading and compelled BOCX to clarify the truth about the histo recaf wich was NEVER approved by the FDA hope they will not lie to us again.
i recommend every investor to think twice before investing in this company.
good luck for all




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.